Lidocaine Accord

Lidocaine Hydrochloride, the active ingredient in Lidocaine Accord, is a local anesthetic presented as a sterile solution for epidural, infiltration and intramuscular use. It provides reversible loss of sensation for surgical and procedural pain management in adult patients. GNH USA supplies Lidocaine Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lidocaine Accord is a local anesthetic used to block nerve transmission in various procedural settings. - Local anesthesia: produces reversible numbness of targeted tissue for minor surgeries. - Epidural analgesia: delivers pain relief during labor or postoperative recovery. - Infiltration anesthesia: numbs a specific area for dental or dermatologic procedures. - Intramuscular analgesia: reduces muscle pain during diagnostic or therapeutic injections.

Adverse reactions may occur following administration of lidocaine.

Common Side Effects: - Burning or stinging at the injection site - Transient dizziness or light‑headedness - Nausea or mild vomiting - Headache - Local swelling or erythema - Metallic taste in the mouth

Serious or Rare Side Effects: - Allergic reactions including anaphylaxis - Cardiac arrhythmias such as ventricular tachycardia - Seizures or convulsions - Methemoglobinemia - Severe hypotension - Respiratory depression or airway obstruction

When using Lidocaine Accord, consider the following safety measures. - Assess patient allergy: verify no known hypersensitivity to lidocaine or amide‑type anesthetics. - Use lowest effective dose: titrate to achieve desired anesthesia while minimizing systemic exposure. - Monitor cardiovascular status: observe heart rate and blood pressure during and after administration. - Avoid in severe hepatic impairment: adjust use or consider alternative agents. - Store at room temperature: keep in original container, protect from light and moisture.

Lidocaine may interact with several medications; awareness of these interactions helps prevent adverse events.

Major Interactions (Avoid): - Class I antiarrhythmics (e.g., quinidine, procainamide) - Amiodarone: can increase lidocaine plasma levels - Cimetidine or erythromycin: may reduce hepatic metabolism - Beta‑blockers: may enhance cardiac depressant effects - General anesthetics (e.g., propofol) in high doses

Moderate Interactions (Monitor Closely): - Other local anesthetics: risk of cumulative toxicity - Calcium channel blockers: may potentiate hypotensive effects - Diuretics (e.g., furosemide): may alter plasma protein binding - Anticonvulsants: monitor for additive CNS effects - Opioids: observe for enhanced sedation or respiratory depression